The largest database of trusted experimental protocols

Rtca software 2

Manufactured by Agilent Technologies
Sourced in United States

The RTCA software 2.0 is a product developed by Agilent Technologies for real-time cell analysis. It provides a platform for monitoring and analyzing cellular responses and behaviors in real-time.

Automatically generated - may contain errors

20 protocols using rtca software 2

1

Real-Time Cell Proliferation and Migration Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proliferation and migration analyses were performed using a xCELLigence Real-Time Cell Analyzer (RTCA) (ACEA Biosciences, San Diego, CA, USA). For measurement of proliferation dynamics, cells were seeded in 200 µL of growth media at a density of 5000 cells/well into an E-plate 16 (ACEA Biosciences, USA). Proliferation curves were evaluated over the course of 72 h with measurements taken every 15 min. Doubling time was analyzed from 8 to 43 h using RTCA software 2.1.0 (ACEA Biosciences, USA). For measurement of migration dynamics, 15,000 cells/mL density were seeded in 100 µL of serum-free media in upper chambers of CIM-plates 16 (ACEA Biosciences). The lower chamber was filled with 160 µL of growth media as a chemoattractant. Cell migration was evaluated over the course of 24 h with measurements taken every of 15 min. Slopes of migration curves were analyzed from 15 to 23 h using RTCA software 2.1.0 (ACEA Biosciences, USA).
+ Open protocol
+ Expand
2

Real-Time Cell Proliferation Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
Real-time monitoring of cell proliferation was performed using the xCelligence RTCA DP system (ACEA Biosciences). Background impedance was measured 30 min after adding 100 μl of culture medium to E-plates 16 PET (ACEA Biosciences). Next, either 2,500 dermal Fb or 3,000 HPASMC per 100 μl of culture medium per well were seeded. After 30 min incubation at room temperature, plates were placed into the xCelligence system. The relative change in electrical impedance termed the Cell Index (CI) was measured. Fb and HPASMC were transfected with negative control or ASO targeting OTUD6B-AS1 26 h or 50 h after seeding, respectively. CI was monitored every 5 min from 0 h to 13 h, every 15 min from 13 h to 25 h and every 30 min from 25 h until CI reached plateau. CI was normalized at the time of transfection for every experiment. The RTCA software 2.0 (ACEA Biosciences) was used to calculate the slope of the CI curve as measure of cell proliferation.
+ Open protocol
+ Expand
3

CTL-Mediated Cytolysis of Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CTL lysis of PDA30364/OVA cells was assessed in vitro using the impedance-based xCELLigence Real-Time Cell Analyzer System (RTCA) (ACEA Biosciences, San Diego, USA). Eighteen h after irradiation, tumor cells were seeded into an E-Plate 96 (ACEA Biosciences) at a density of 7.2 × 103 cells/well and rested overnight at 37 °C. Next day, CTLs were added at an effector/tumor cell ratio of 2.5:1. PD-L1-specific antibody (20 µg/ml) (Bio X Cell, Inc., West Lebanon, USA) was added 3 h prior to CTL addition and at the time point the co-culture was started, resulting in a final concentration of 10 μg/ml αPD-L1 antibody. The cell index (CI), representing the relative impedance as a measure for the number of adherent cells was determined every 5 min for at least 24 h. CI values were normalized to the time point of CTL addition using the RTCA Software 2.0 (ACEA Biosciences). Percentage cytolysis was calculated according to the formula: Cytolysis [%] = ((CIwo.CTLs − CIw.CTLs)/CIwo.CTLs) × 100. Standard deviation (SD) of mean CI values was calculated using error propagation formulas established by the Biostatistics Department of the DKFZ. Specificity of the CTL line was controlled using parental PDA30364 cells in comparison to PDA30364/OVA cells as described previously25 (link). “Kill-Time-50” (KT50) was defined as time span between CTL addition and eradication of 50% of PDA30364/OVA cells.
+ Open protocol
+ Expand
4

Real-Time Cell Proliferation Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
Real-time cell proliferation monitoring was performed with the RTCA DP xCelligence system (ACEA Biosciences, San Diego, CA, USA). The equipment was placed in a cell culture incubator (37 °C, 5% CO2, humidified incubator). The resistance values measured by the device were quantified as the cell index (CI). Twelve thousand cells were seeded per well of the 16-well E-plates with an area of 0.3 cm2 (12,000 cells/well) according to the manufacturer’s procedure. Twenty-four hours after the start of the measurements, the chemotherapeutic agents were added at the appropriate concentrations. Cell proliferation was monitored for the period of time indicated in the respective figures. Data analysis was carried out with the RTCA Software 2.0 (ACEA Biosciences, San Diego, CA, USA) and GraphPad Prism 6.
+ Open protocol
+ Expand
5

CDKN2A Knockdown Impacts BM-MSC Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Since the CDKN2A might be important in proliferation activity in patient's BM‐MSCs, we performed CDKN2A KD experiment and analysed proliferation activity using a real‐time cell monitoring system. CDKN2A KD was performed by small interfering RNA (siRNA) with specific sequence of 5′‐CCGUAAAUGUCCAUUUAUATTUAUAAAUGGACAUUUAUGGTT‐3′ designed and synthesized by GenePharma (Shanghai GenePharma, Shanghai, China). BM‐MSCs at third passage (1.0 × 104) were suspended in 150 μl of antibiotic‐free basic cell culture medium and seeded into each well of the E‐plate 16 (ACEA Biosciences Inc, San Diego, USA) and then installed into xCELLigence RTCA DP system (ACEA Biosciences Inc). After 24 hr, cells were transfected with 50 nM CDKN2A‐siRNA using Lipofectamine RNAiMAX (Invitrogen Life Technologies, Carlsbad, CA, USA). Untreated, Lipofectamine RNAiMAX treated and negative control siRNA (no genetic homology with human siRNA, GenePharma) treated cells were used as controls. The proliferation activity was measured every 10 min for following 3 days and analyses using RTCA software 2.0 (ACEA Biosciences Inc).
+ Open protocol
+ Expand
6

Cisplatin and Doxorubicin Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
5 × 103 cells were seeded in each well of E-plate 16 (ACEA Biosciences) and placed in the xCELLigence RTCA DP Instrument (ACEA Biosciences) in 37°C, 5% CO2 humidified incubator. After 24 h cisplatin was added and cells propagation was monitored with RTCA Software 2.0 (ACEA Biosciences). For experiments with Doxorubicin dose response, the addition time was moved to 48 hours, and initial seeding was 2.5 × 103 cells. Subsequent data analysis was carried out with the RTCA and PRISM 6 software.
+ Open protocol
+ Expand
7

Immortalized hCMEC/D3 Cells for BBB Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human cerebral microvascular endothelial cell line (hCMEC/D3) is an immortalized line that retains BBB characteristics in vitro (Weksler et al., 2005 (link)). hCMEC/D3 cells were seeded onto 3 independent collagen-coated 16-well E-Plate PET arrays (ACEA Biosciences, San Diego, CA) at a concentration of 20,000 cells/well and loaded onto an xCelligence RTCA DP system (ACEA Biosciences) enclosed in a tissue culture incubator. Once cells reached confluence ~ 24 h after seeding, duplicate wells in each array were treated with 200 μl of the following: vehicle (DMSO, 0.3%), tissue-nonspecific alkaline phosphatase inhibitor (TNAPi 100 μM; Millipore, Temecula, CA), lipopolysaccharide (LPS 100 ng/mL; Sigma-Aldrich, Milwaukee, WI), or LPS (100 ng/ml) and TNAPi (100 μM). Cell index (CI) was recorded continuously for 24 h and analyzed with RTCA Software 2.0 (ACEA Biosciences). CI for all wells was normalized to a single timepoint, i.e. ~1 h after treatment and reported as normalized CI.
+ Open protocol
+ Expand
8

Real-Time Cell Proliferation and Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Impedance-based real time detection of cell proliferation and viability was done using the xCELLingence technology of the RTCA SP system (ACEA Biosciences, Ozyme, France). 4T1 or MDA-MB-231 breast cancer cells were seeded in E-Plate 96-well plates (5 × 103 cells/well) for 24 hours, and were treated with metformin 1–7.5 mM alone, propranolol 10 μM alone, or their combinations. At cell seeding and after drug administration impedance changes were monitored every 5 minutes for 8 hours, and every 15 minutes for the rest of the experiment. Cell index (CI) values derived from the recorded impedance data, were normalized (NCI) using the RTCA Software 2.0 (ACEA Biosciences, Ozyme, France). Data of each single well were normalized to the first measurement after starting treatment using the equation NCI(time) = CItime/CInml time.
+ Open protocol
+ Expand
9

Proliferation Assays in Renal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Colony formation assay and RTCA (Real‐time cell analysis) assay were used to detect the proliferation of renal cancer cells. Colony formation assay: In the first group, cells (786‐O and ACHN) were seeded into 6‐cm cell culture dishes (1000–1500 cells per dish) and incubated with sigma‐2 receptor antagonist 1 (0 nM, 100 nM, 500 nM and 1000 nM) for 14 days. In the second group, 786‐O and ACHN cells were inoculated as mentioned above (1000–1500 cells per dish). Thereafter, cells were cultured with various concentrations of PB28 (0 μM, 1 μM, 5 μM and 10 μM). After 8–14 days, the proliferation of cells in both groups was determined by the crystal violet staining assay. RTCA assay: RTCA (ACEA Biosciences, USA) was performed to monitor cell viability according to the manufacturer's instructions. The xCELLigence software began to record the electrical values when cells adhere to the surface of the plate and influenced. The actual experiment began, cells were mixed with 100 μl of culture medium and seeded into plates after the background value measured. Culture medium containing PB28 (H₂O) or sigma‐2 receptor antagonist 1 (DMSO) was added, respectively. All data were documented with ACEA Biosciences RTCA software 2.0 and analysed by GraphPad Prism 5.
+ Open protocol
+ Expand
10

Real-time monitoring of ADI treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor cells (6×103) were seeded into 16-well E-plates (Acea Bioscience, USA) in 200 uL medium. After seeding, cells were monitored every 15 min by the xCELLigence® RTCA DP (Acea Bioscience, USA). After a 24 h cell attachment period, cells were treated with 0.15 μg/mL ADI. Real-time cell index and relative slopes (1/h) deduced from the proliferation curves were generated by RTCA software 2.0 (Acea Bioscience, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!